NICE explores extending its use of data to inform its guidance

25 June 2019 - NICE has revised its earlier press release on the use of real world data to inform ...

Read more →

Quality assurance of registries for health technology assessment

25 September 2018 - The aim of this study was to identify guidelines and assessment tools used by health technology agencies ...

Read more →

Using evidence from randomised controlled trials in economic models: what information is relevant and is there a minimum amount of sample data required to make decisions?

21 September 2018 - Evidence from randomised controlled trials is used to support regulatory approval and reimbursement decisions.  ...

Read more →

Assessing the value of innovative devices and diagnostics: the importance of clear and relevant claims of benefit

20 July 2018 - Large numbers of new medical devices and diagnostics are developed and health services need to identify which ...

Read more →

Can ad hoc analyses of clinical trials help personalise treatment decisions?

23 October 2017 - The value of ad hoc analyses of clinical trials may not be clear. Ad hoc analyses are ...

Read more →

Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples

13 September 2017 - Organisations such as the NICE require the synthesis of evidence from existing studies to inform their decisions—for ...

Read more →